Columbia Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$223K Buy
2,860
+75
+3% +$6.62K 0.05% 175
2021
Q3
$266K Sell
2,785
-380
-12% -$40.1K 0.06% 159
2021
Q2
$393K Buy
3,165
+740
+31% +$88.3K 0.09% 136
2021
Q1
$320K Buy
2,425
+220
+10% +$30.1K 0.06% 154
2020
Q4
$292K Sell
2,205
-270
-11% -$32.7K 0.06% 152
2020
Q3
$252K Buy
+2,475
New +$214K 0.06% 148
2020
Q1
Sell
-4,620
Closed -$4.27K 153
2019
Q4
$4.27K Sell
4,620
-550
-11% -$48.4K 0.1% 131
2019
Q3
$467K Sell
5,170
-350
-6% -$39.9K 0.12% 124
2019
Q2
$652K Buy
5,520
+825
+18% +$83.1K 0.17% 98
2019
Q1
$407K Buy
+4,695
New +$400K 0.11% 127

Other funds holding EXAS

Columbia Asset Management's EXAS Position: Q4 2021 in Review

Columbia Asset Management increased its Exact Sciences (EXAS) stake by 2.7% in Q4 2021, buying an estimated $6.62K and bringing the position to 2,860 shares worth $223K. The position accounts for 0.05% of the portfolio, ranked #175.

Columbia Asset Management first reported a position in EXAS in Q1 2019 and has held it in 10 quarters since. The position peaked at $652K in Q2 2019. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • Columbia Asset Management held 2,860 shares of Exact Sciences worth $223K as of Q4 2021.
  • Columbia Asset Management bought 75 Exact Sciences shares in Q4 2021, an estimated $6.62K.
  • Exact Sciences made up 0.05% of Columbia Asset Management's portfolio in Q4 2021, its #175 holding.
  • Columbia Asset Management first reported a position in Exact Sciences in Q1 2019 and has held it in 10 quarters since.
  • Columbia Asset Management's Exact Sciences position peaked at $652K in Q2 2019.
  • 596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Columbia Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.